Bioptimus Assembles Elite Scientific Advisory Board to Build Next-Gen AI Models for Biology
Eight internationally renowned experts join Bioptimus to pioneer large-scale foundation models that will transform science and medicine PARIS, Sept. 11,...
Eight internationally renowned experts join Bioptimus to pioneer large-scale foundation models that will transform science and medicine PARIS, Sept. 11,...
Spectral Flow Cytometry Pioneer Unveils Innovations Accelerating Efficiency and DiscoveryFREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research...
NEW YORK, Sept. 10, 2025 /PRNewswire/ -- DocPanel Technologies, the leading subspecialty radiology platform offering access to the largest network of...
Close to $600,000 in Funding Provided to 14 Academic Researchers from Across the US to Advance New Innovations to Predict,...
PALO ALTO, CALIFORNIA / ACCESS Newswire / September 10, 2025 / Bioz, Inc., an AI technology company transforming how scientists...
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Kim Kelderman will be joining its Board of Directors effective September...
VACAVILLE, CA / ACCESS Newswire / September 9, 2025 / Vacaville Aesthetic Dentistry & Implants, led by Dr. Coral Posert,...
Full-Service Laboratory Management Firm Helps Elevate Clinical Lab Operations NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Henry Schein Medical, the...
Full-Service Laboratory Management Firm Helps Elevate Clinical Lab Operations NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Henry Schein Medical, the...
SALT LAKE CITY, Sept. 9, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with...
SALT LAKE CITY, Sept. 9, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with...
Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path...
Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path...
In the study, TissueCypher identified that 15% of patients with non-dysplastic Barrett's esophagus (NDBE) had a probability of progression that...
Veteran life sciences industry financing leader appointed as new Board memberHOLLISTON, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience,...
DELRAY BEACH, Fla., Sept. 8, 2025 /PRNewswire/ -- The global Wearable Healthcare Devices Market, valued at US$41.07 billion in 2024,...
MESA, ARIZONA / ACCESS Newswire / September 8, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) (the "Company" or "MDCE")...
PARTNERING WITH PAUL & ALBRECHT PATENT LAWYERS CHEYENNE, WYOMING / ACCESS Newswire / September 8, 2025 / CS Diagnostics Corp....
5,000-participant, multi-center registry supported by iMDx’s central lab and transplant center partnersNew hospital-based data seeks to further differentiate pending kitted...
iMDx’s ClinicalTrials.gov listing now names 10 leading transplant centers, up from 5 previouslyGraftAssureDx remains on track for FDA submission by...